SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Mimedx Group, Inc. – ‘10-K’ for 12/31/13 – ‘EX-10.5’

On:  Tuesday, 3/4/14, at 4:11pm ET   ·   For:  12/31/13   ·   Accession #:  1376339-14-5   ·   File #:  1-35887

Previous ‘10-K’:  ‘10-K’ on 3/15/13 for 12/31/12   ·   Next:  ‘10-K/A’ on 4/30/14 for 12/31/13   ·   Latest:  ‘10-K’ on 2/28/24 for 12/31/23   ·   4 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/04/14  Mimedx Group, Inc.                10-K       12/31/13   81:10M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    790K 
 2: EX-10.3     Material Contract                                   HTML     33K 
 3: EX-10.4     Material Contract                                   HTML     32K 
 4: EX-10.5     Material Contract                                   HTML     31K 
 5: EX-23.1     Consent of Experts or Counsel                       HTML     22K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     29K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     29K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     24K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     24K 
57: R1          Document and Entity Information                     HTML     50K 
46: R2          Consolidated Balance Sheets                         HTML    124K 
55: R3          Consolidated Balance Sheets (Parenthetical)         HTML     49K 
59: R4          Consolidated Statements of Operations               HTML     81K 
75: R5          Consolidated Statements of Stockholders' Equity     HTML    151K 
48: R6          Consolidated Statements of Stockholders' Equity     HTML     25K 
                (Parenthetical)                                                  
54: R7          Consolidated Statements of Cash Flows               HTML    156K 
42: R8          Consolidated Statements of Cash Flows               HTML     24K 
                (Parenthetical)                                                  
32: R9          Nature of Business                                  HTML     26K 
76: R10         Significant Accounting Policies                     HTML     62K 
61: R11         Liquidity and Management's Plans                    HTML     24K 
60: R12         Inventories                                         HTML     37K 
66: R13         Property and Equipment                              HTML     41K 
67: R14         Intangible Assets and Royalty Agreement             HTML     66K 
64: R15         Long-Term Debt                                      HTML     47K 
68: R16         Net Income (loss) Per Share                         HTML     56K 
56: R17         Common Stock Placements                             HTML     38K 
58: R18         Equity                                              HTML    218K 
63: R19         Income Taxes                                        HTML     64K 
81: R20         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     69K 
                Investing and Financing Activities                               
71: R21         Related Party Transactions                          HTML     47K 
51: R22         401k Plan                                           HTML     33K 
62: R23         Commitments and Contingencies                       HTML     42K 
53: R24         Quarterly Financial Data (Unaudited)                HTML     80K 
25: R25         Schedule II - Valuation and Qualifying Accounts     HTML     57K 
                (Notes)                                                          
72: R26         Significant Accounting Policies (Policies)          HTML    157K 
78: R27         Inventories (Tables)                                HTML     35K 
37: R28         Property and Equipment (Tables)                     HTML     38K 
36: R29         Intangible Assets and Royalty Agreement (Tables)    HTML     65K 
40: R30         Long-Term Debt (Tables)                             HTML     40K 
41: R31         Net Income (loss) Per Share (Tables)                HTML     56K 
43: R32         Equity (Tables)                                     HTML    224K 
23: R33         Income Taxes (Tables)                               HTML     57K 
69: R34         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     66K 
                Investing and Financing Activities (Tables)                      
50: R35         Related Party Transactions (Tables)                 HTML     43K 
52: R36         Commitments and Contingencies (Tables)              HTML     30K 
28: R37         Quarterly Financial Data (Unaudited) (Tables)       HTML     77K 
80: R38         Nature of Business (Details)                        HTML     24K 
17: R39         Significant Accounting Policies (Details)           HTML     61K 
44: R40         Liquidity and Management's Plans (Details)          HTML     34K 
74: R41         Inventories (Details)                               HTML     40K 
27: R42         Property and Equipment (Details)                    HTML     43K 
35: R43         Intangible Assets and Royalty Agreement (Details)   HTML    132K 
39: R44         Long-Term Debt (Schedule of Debt Instruments)       HTML     37K 
                (Details)                                                        
47: R45         Long-Term Debt (Details)                            HTML     83K 
22: R46         Net Income (loss) Per Share (Details)               HTML     73K 
31: R47         Common Stock Placements (Details)                   HTML     37K 
19: R48         Equity (Narrative) (Details)                        HTML     42K 
73: R49         Equity (Activity of Stock Options) (Details)        HTML     86K 
26: R50         Equity (Exercise Price Ranges) (Details)            HTML     63K 
70: R51         Equity (Summary of Unvested Stock Options)          HTML     41K 
                (Details)                                                        
29: R52         Equity (Assumptions) (Details)                      HTML     38K 
45: R53         Equity (Summary of Restricted Stock Awards)         HTML     63K 
                (Details)                                                        
18: R54         Equity (Recognized Stock-Based Compensation)        HTML     30K 
                (Details)                                                        
21: R55         Equity (Warrants) (Details)                         HTML     71K 
38: R56         Income Taxes (Details)                              HTML     90K 
24: R57         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     93K 
                Investing and Financing Activities (Details)                     
77: R58         Related Party Transactions (Details)                HTML     36K 
49: R59         401k Plan (Details)                                 HTML     35K 
65: R60         Commitments and Contingencies (Details)             HTML     40K 
30: R61         Quarterly Financial Data (Unaudited) (Details)      HTML     43K 
33: R62         Schedule II - Valuation and Qualifying Accounts     HTML     35K 
                (Details)                                                        
79: XML         IDEA XML File -- Filing Summary                      XML    114K 
20: EXCEL       IDEA Workbook of Financial Reports                  XLSX    204K 
34: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   1.48M 
10: EX-101.INS  XBRL Instance -- mdxg-20131231                       XML   2.43M 
12: EX-101.CAL  XBRL Calculations -- mdxg-20131231_cal               XML    199K 
13: EX-101.DEF  XBRL Definitions -- mdxg-20131231_def                XML    511K 
14: EX-101.LAB  XBRL Labels -- mdxg-20131231_lab                     XML   1.82M 
15: EX-101.PRE  XBRL Presentations -- mdxg-20131231_pre              XML    918K 
11: EX-101.SCH  XBRL Schema -- mdxg-20131231                         XSD    178K 
16: ZIP         XBRL Zipped Folder -- 0001376339-14-000005-xbrl      Zip    249K

‘EX-10.5’   —   Material Contract

This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]

 <!   C:   C: 
  MDXG- 2013.12.31 10-K Ex 10.5 NQ Agmt  

MIMEDX GROUP, INC.
ASSUMED 2006 STOCK INCENTIVE PLAN

Nonqualified Stock Option Agreement
(Non-employee Directors and Independent Contractors)



1.    Pursuant to the terms and conditions of the Corporation's Assumed 2006 Stock Incentive Plan (the "Plan"), you (the "Participant") have been granted an option (the "Option") to purchase __________ shares (the "Shares") of our Common Stock as outlined below.
        
 
Name of Participant:
 
 
 
 
Address:
 
 
 
 
 
 
 
 
 
Grant Date:
 
 
 
 
Number of Shares Subject to Option:
 
 
 
 
Option Price:
 
$
 
 
Type of Option:
 
Nonqualified Stock Option
 
 
Expiration Date (Last day of Option Period):
 
 
 
 
Vesting Schedule/Conditions:
 
33.33% on
 
 
 
 
66.66% on
 
 
 
 
100% on
 

2.    By my signature below, the Participant hereby acknowledges receipt of this Nonqualified Stock Option Agreement (the "Agreement") and a copy of the Plan, and furthermore, the Participant agrees to be bound by the terms of the Plan and the Agreement. The Participant understands that the applicable provisions of the Plan are hereby incorporated by reference into the Agreement and constitute a part of the Agreement. The Corporation reserves the right to treat the Option and the Agreement as cancelled, void and of no effect if the Participant fails to return a signed copy of this Grant Notice within 30 days of receipt of this Grant Notice.


 
 
 
 
 
Signature:
 
 
Date:
 
 
 
 
 
 
 
 
 
Agreed to by:
 
 
 
 
 
 
 
 
MiMedx Group, Inc.
 
 
 
 
 
 
 
 
By:
 
 
 
 
Name: Parker H. Petit
 
 
 
Its: Chairman and Chief Executive Officer
 
 
 
 
 
Attest:
 
 
 
 
 
 
 
 
 
Vice President, Human Resources and Administration
 
 
 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/4/14
For Period end:12/31/1310-K/A
 List all Filings 

4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/24  Mimedx Group, Inc.                10-K       12/31/23  116:11M
 2/28/23  Mimedx Group, Inc.                10-K       12/31/22  123:13M
 2/28/22  Mimedx Group, Inc.                10-K       12/31/21  112:13M
 3/08/21  Mimedx Group, Inc.                10-K       12/31/20  111:12M
↑Top
Filing Submission 0001376339-14-000005   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., Apr. 30, 4:41:55.1pm ET